Home

Monoclonal antibodies production

Producing mAb requires immunizing an animal, usually a mouse; obtaining immune cells from its spleen; and fusing the cells with a cancer cell (such as cells from a myeloma) to make them immortal, whic This unit describes the production of monoclonal antibodies beginning with immunization and cell fusion and selection Production of monoclonal antibodies. The production of monoclonal antibodies is done by either of two methods. In Vitro Methods (Using cell lines in glassware) In the Vivo method (Using living animals like Mice) In Vitro Method. In this method, the monoclonal antibodies are produced by fusing normally activated antibody-producing B-cells with myeloma cells Milstein and Köhler described the first technique developed for stable monoclonal antibody production in 1975. This technique consists of creating a hybridoma, a stable hybrid cell capable of producing a single type of antibody against a specific epitope present in an antigen. Hybridoma construction was initially produced from murine models A typical monoclonal antibody production process Immunization of mice & isolation of splenocytes - Mice are immunized with an antigen and later their blood is screened for antibody production. The antibody-producing splenocytes are then isolated for in vitro hybridoma production.; Preparation of myeloma cells - Myeloma cells are immortalized cells that, once fused with spleen cells, can result.

The production of monoclonal antibodies is an in vitro process by the use of the tissue-culture techniques. Producing monoclonal antibodies (mAbs) is initially done by identifying a specific antigen, immunizing an animal with the antigen multiple times. The most commonly used animal models are laboratory mice The production of monoclonal anti-bodies was first invented by Cesar Milstein, Georges J. F. Köhler and Niels Kaj Jerne in 1975. Selection occurs via culturing the newly fused primary hybridoma..

Monoclonal antibody production We propose monoclonal antibody production depending on your needs: from small to large scale in vivo (ascites production) or in vitro (hybridoma cell culture, recombinant antibody production, stable cell line generation) The production of custom antigen specific mouse monoclonal antibody is a time consuming and technically demanding process. The production of antibodies is conducted at our state-of-the-art facilities either in the US or UK, utilizing Envigo purpose bred models

  1. Production of Monoclonal Antibodies: The establishment of hybridomas and production of MAbs involves the following steps (Fig. 17.2). 1. Immunization . 2. Cell fusion . 3. Selection of hybridoma
  2. Monoclonal antibodies are produced against a variety of proteins, glycoproteins, glycolipids, nucleic acids and chemically defined groups linked to protein carriers. Hybridoma technology for production of monoclonal antibodies: Monoclonal antibodies are produced by hybridoma technology
  3. Monoclonal antibodies are identical copies of one type of antibody. Antibodies are proteins produced by a type of white blood called lymphocytes. Pathogens have proteins on their surface called..
  4. Suggested Citation:Large-Scale Production of Monoclonal Antibodies.National Research Council. 1999. Monoclonal Antibody Production.Washington, DC: The National.
  5. Monoclonal antibodies production 1. C Sworna kumari.,M.Sc.,M.Phil 2. The monoclonal antibody (mAb) production process usually starts with generation of mAb-producing cells (i.e. hybridomas) by fusing myeloma cells with desired antibody-producing splenocytes (e.g. B cells). These B cells are typically sourced from animals, usually mice. After cell fusion, large numbers of clones are screened.

Production of Monoclonal Antibodies 5 Steps and Application

Monoclonal antibodies (mAbs) are produced by introducing an antigen to a mouse and then fusing polyclonal B cells from the mouse's spleen to myeloma cells. The resulting hybridoma cells are cultured and continue to produce antibodies to the antigen A monoclonal antibody (mAb or moAb) is an antibody made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to a unique parent cell. Monoclonal antibodies can have monovalent affinity, binding only to the same epitope (the part of an antigen that is recognized by the antibody) Monoclonal antibodies are created by the fusion of antibody producing cells with in vitro cultured immortalized malignant myeloma cells, resulting in a hybridoma cell. As these hybridoma cells retain some of the properties of a B-cell, they are able to generate and secrete antibodies

Production Processes for Monoclonal Antibodies IntechOpe

Monoclonal Antibody Development Service Overview Sino Biological offers fully custom monoclonal antibody production services for pharmaceutical companies and research institutes. Our professional peptide design software and high-efficiency conjugation methods ensure the success rate of peptide immunization greater than 95% Monoclonal Antibody and Recombinant Protein Production. The number of licensed immunotherapies based upon monoclonal antibodies (mAb) and recombinant proteins has grown rapidly over the last 30 years. Despite this growth, most current monoclonal antibody production processes remain closely related to those established by the early processes. Monoclonal antibodies are typically made by fusing myeloma cells with the spleen cells from a mouse that has been immunized with the desired antigen. However..

Monoclonal Antibody Production. In reviewing proposals which include the mouse ascites method, the ARC is required by federal regulations to determine that (i) the use of the ascites method for producing monoclonal antibodies (mAbs) is scientifically justified, (ii) methods that avoid or minimize discomfort, distress, and pain (including in. Monoclonal Antibody Production. A hollow fiber bioreactor from FiberCell ® Systems is the ideal method for the in vitro production of 25mg on up to gram quantities of a monoclonal antibody. A technologically advanced high-gross-filtration rate hydrophilic polysulfone fiber with a molecular weight cut off (MWCO) of 20kd is specified

Introduction. Monoclonal antibodies (mAb) are important reagents used in biomedical research, in diagnosis of diseases, and in treatment of such diseases as infections and cancer. These antibodies are produced by cell lines or clones obtained from animals that have been immunized with the substance that is the subject of study Monoclonal antibodies have been used for testing kits and medical therapies across a wide range of applications. The most recent is to provide a potential treatment for patients suffering from Covid-19 infection. The production of monoclonal antibodies is well understood, scalable and standardized to the extent that it makes a good generic example of a modern bioprocess. This aspect will be. Preface - Monoclonal Antibody Production - NCBI Bookshelf. Monoclonal antibodies (mAb) are used extensively in basic biomedical research, in diagnosis of disease, and in treatment of illnesses, such as infections and cancer. Antibodies are important tools used by many investigators in their research and have led to many medical advances

The traditional monoclonal antibody (mAb) production process usually starts with generation of mAb-producing cells (i.e. hybridomas) by fusing myeloma cells. In this video lecture we will studyMonoclonal AntibodiesTechnique of Monoclonal antibody production: Hybridoma TechnologyReferences:1. Biotechnology, U. Saty.. Producing monoclonal antibodies in vitro via transient systems is still the best way to produce small amounts of antibodies for measuring: Affinity/avidity; Specificity/selectivity; Aggregation profile; Stability; Ease of purification; Ease of scalability; Detectable problems at this stage can be corrected by additional engineering of antibody leads The industrial production of monoclonal antibodies starts in the laboratory 3 by inserting an antigen (a molecule that can trigger immune response) into a mouse. The mouse starts to produce B lymphocytes (antibody-producing cells) to defend itself against the antigen 4. These cells have a short life span and fuse with immortal tumour cells. ADVERTISEMENTS: Read this article to learn about the production and uses of monoclonal antibodies! Production: 1. A mouse is injected with a specific antigen that will induce antibodies against that antigen. 2. The spleen of the mouse is removed and a suspension is made. The suspension includes В cells that produce antibodies against the injected [

Monoclonal Antibody Production, mAb Molecular Device

The methods employed for human and mouse monoclonal antibody production and generation are illustrated along with the generation of hybrid hybridomas. Several key problems are found in the production of human and mouse monoclonal antibodies and are discussed with an emphasis on manufacturing considerations The scope of this guideline includes monoclonal antibodies derived from hybridoma cell lines or from cells genetically engineered to express a monoclonal antibody. Whenever production of monoclonal antibodies is performed using animals (e.g. engineered animals or harvest from ascites fluid), IC With monoclonal antibody technologies such as hybridoma technology, proprietary rabbit monoclonal antibody technology and single B cell technology, thousands of monoclonal antibodies have been developed and manufactured for customers. Our fast mouse monoclonal antibody service can be delivered in just 60 days Monoclonal Antibody production InVivo is your partner for custom monoclonal antibody production from hybridoma cell lines. More than 3,500 different hybridoma clones producing human, rat, or mouse antibodies have been processed in our lab during the last 20 years In Vitro Production of Monoclonal Antibody 12-15; Scientific Needs for Mouse Ascites Production of mAb 16-21; Summary of Advantages and Disadvantages of In Vitro and In Vivo Methods 22-24; Large-Scale Production of Monoclonal Antibodies 25-32; Animal-Welfare Issues Related to the Ascites Method for Producing Monoclonal Antibodies 33-4

Monoclonal antibodies (mAb) are used extensively in basic biomedical research, in diagnosis of disease, and in treatment of illnesses, such as infections and cancer. Antibodies are important tools used by many investigators in their research and have led to many medical advances The protein and monoclonal antibody production core is a shared research resource to provide quality purified protein and monoclonal antibody. These services includes the protein expression and purification in E.coli, insect and mammalian systems. The core also has had more than 20-year excellent experience in producing new monoclonal. Monoclonal antibody, antibody produced artificially through genetic engineering and related techniques. Production of monoclonal antibodies was one of the most important techniques of biotechnology to emerge during the last quarter of the 20th century Currently, monoclonal antibodies can easily achieve high expression in mammalian cell culture. These driving factors led to the discovery of significant improvements in platform technology. In addition, in order to achieve these needs, there are also some new trends in biopharmaceutical production processes Monoclonal antibody services. ProSci offers custom monoclonal antibody development services using hybridoma development technology through comprehensive packages to fulfill your antibody needs. We understand researchers have a wide array of needs and levels of involvement in developing monoclonal antibodies depending on your target

Monoclonal Antibodies- Definition, Types, Production

Monoclonal antibodies. are identical copies of one type of antibody. Antibodies are proteins produced by a type of white blood called lymphocytes . Pathogens have proteins on their surface called. Monoclonal antibodies are synthetic versions of the body's antibodies produced in a laboratory and are designed to restore, mimic, inhibit or enhance immune system functions. While much of the recent focus of these products has been on COVID-19, monoclonal antibodies are also used to fight diseases such as cancer, rheumatoid arthritis and. Custom Monoclonal Antibody Production. Although BioServUK treats each contract as a custom project, most of the following elements are applicable and help to ensure a quality product is produced: Consultation with client to discuss antigen selection

(PDF) Production of Monoclonal Antibodie

For the production of large quantities of monoclonal antibodies (over 100 mg) RD-Biotech can carry out a productivity assessment on small volumes (pilot step). At the end of this feasibility phase, the customer receives a report indicating the productivity and an adaptated quotation for the production phase Monoclonal Antibody Production. To create monoclonal antibodies an immunogen is first injected into a host animal. Once an immune response has been caused by the immunogen, the B-cells from the.

As immunoglobulin (Ig) G monoclonal antibodies, the authorized anti-SARS-CoV-2 monoclonal antibodies would be expected to cross the placenta. There is no pregnancy-specific data on the use of these monoclonal antibodies; however, other IgG products have been safely used in pregnant people when their use is indicated Production & Purification of your Antibodies 1 - 2 months. Antibody production from hybridoma/antibody producing clones that we store for you in our lab or from hybridoma cells you send us. Davids established different purification steps to purify IgG, IgM and other subclasses. For further information go to our Monoclonal Antibody Production page Monoclonal antibodies can be produced in specialized cells through a method now referred to as hybridoma technology. Kohler and Milstein in 1975, were the first to fuse lymphocytes to generate a cell line, both immortal and a producer of specific antibodies. They won the Nobel Prize for Medicine in 1984 for the development of 'hybridoma' Monoclonal antibodies should be stored at 2-80 temperature. Protected from light and kept in a brown color bottle. Not allow freezing. Advancement/ Improvement in Hybridoma Technology. During the last 10-15 years have been made to improve the production of monoclonal antibodies using Hybridoma technology

Cell Fusion and Antibody Production The results of the fusion following immunization with progesterone antigen are summarized in Table 1. Two hybridoma cell lines (MAM 2H11, MAM 6G6) producing specific monoclonal antibodies to progesterone were selected from this fusion. Table 1. Results of Fusion Fusion 1 Fusion 2 Number of spleen cells 3.108. The monoclonal antibody was produced through classical cell fusion. First, eight female BALB/c mice were subcutaneously immunized with immunogen. After three immunizations and serum monitoring, the mice that possessed higher antiserum titres and lower IC 50 values were selected using checkerboard assays for subsequent cell fusion A major stumbling block was the fact that the production of early monoclonal antibodies was limited by whether or not there was a suitable myeloma cell line available (usually mouse or rat). Hybridomas may also be low yielding or genetically unstable . More recently, many different expression systems for monoclonal antibodies have been tested. Monoclonal antibodies (mAbs) are monovalent antibodies which bind to the same epitope and are produced from a single B-lymphocyte clone. Monoclonal antibodies are important tools used in biomedical research, in diagnosis of diseases, and in treatment of such diseases as infections and cancer Monoclonal antibodies (-mabs) are a common source of confusion for pharmacy students. They have long, hard-to-pronounce names that all look and sound alike. It's impossible to tell them apart, let alone keep track of where they're used therapeutically. Well that ends today, you smarty pants tl;dr pharmacy reader, you

Monoclonal antibody production - ProteoGeni

That is, a monoclonal antibody is a collection of the antibodies secreted by a single B-cell clone, therefore having specificity for only one antigenic epitope. Production of Commercial Antibodies. In general, it is much simpler to produce a polyclonal than a monoclonal antibody Main Difference - Monoclonal vs Polyclonal Antibodies. Antibodies are a type of globular proteins produced by the plasma B cells in response to a specific antigen.An antigen can be a foreign molecule that interacts with the cells of the immune system, triggering an immune response.The molecules on the antigens to which the antibodies attach themselves are called epitopes Production of Monoclonal Antibodies for patient therapy-Working with Lonza Bioscience, the Company will produce stable cell lines for mass producing multiple Monoclonal Antibodies for application in the early stages of infection to treat or cure patients infected by the targeted virus Abstract The disulfide reduction of intact monoclonal antibodies (mAbs) and subsequent formation of low molecular weight (LMW) species pose a direct risk to product stability, potency, and patient safety. Although enzymatic mechanisms of reduction are well established, an understanding of the cellular mechanisms during the bioreactor process leading to increased risk of disulfide reduction. Monoclonal antibodies are laboratory-made molecules that in this case mimic the immune system response to SARS-CoV-2, targeting a specific portion of the protruding spike proteins on the.

Polyclonal Antibodies vs. Monoclonal Antibodies: Production. Polyclonal antibodies (pAbs) are mixture of heterogeneous which are usually produced by different B cell clones in the body. They can recognize and bind to many different epitopes of a single antigen. Polyclonal antibodies are produced by injecting an immunogen into an animal Monoclonal antibodies are a new treatment for outpatients with COVID-19 who are at risk of progression to severe disease. An antibody is a protein that is naturally produced by the immune system in response to an infection. A monoclonal antibody is a molecule developed in a laboratory that is designed to mimic or enhance the body's natural.

Monoclonal antibody production - ENVIG

  1. Using the Company's proprietary methodology for producing fully human monoclonal antibodies, the Company is producing antibodies targeting these virus sites in its lab at Texas A&M University in.
  2. istration of combination therapy. Creation of cell lines to produce fully human monoclonal antibodies targeting each identified conserved virus site (epitope). In this step, multiple broadly neutralization antibodies are produced.
  3. g purification. Because of the expensive and time-consu
  4. The majority of monoclonal antibodies are made using fusion proteins because they can be produced in large quantities and most closely resemble, or are identical to, native protein. The first step in the production of monoclonal antibodies is the expression of the purified antigen. This often underappreciated step is critical to the success of.
Monoclonal antibody production using Hybridoma Technology

Monoclonal Antibodies: Production, Advantages and Limitation

murine antibody therapy and several manufacturing problems in the production of human monoclonal antibodies is the production of so called chimeric and humanised monoclonal antibodies using recombinant DNA (rDNA) technology and eukaryotic gene expression methods. Both types of rDNA-engineered monoclonal antibodies contain human sequences The cost of production of hybridomas and of obtainment of monoclonal antibodies is formed individually and depends on the following factors: the structure of an antigen and the need for its accumulation, the complexity and availability of hybridoma selection technique, the required antibodies producing abilities, the quantity of hybridomas that produce antibodies for different epitopes, the. A few words about controversy. The European legislation has recently restricted the use of living animals for scientific purposes (see the directive 2010/63/EU published in the Official Journal of the European Union), and especially for the production of monoclonal antibodies within ascites. Indeed, animals can feel the stress and pain caused by such methods, and must be used only as a last. Monoclonal Antibody Production in the Mouse Monoclonal antibodies are important tools both for basic research as well as for medical treatment. Monoclonal antibodies are created by first immunizing an animal (typically a mouse) with the antigen of interest, harvesting its spleen after determination of successful polyclonal antibod monoclonal antibody, expression systems, cell line engineering, cell culture process development, optimization scale-up and technology transfer, process advances are often working on therapies for similar targets and clinical indications. Since antibody therapies may require large doses ove

The production of monoclonal antibodies allows the isolation of reagents with a unique, chosen specificity. Because all of the antibodies produced by descendants of one hybridoma cell are identical, monoclonal antibod-ies are powerful reagents for testing for the presence of a desired epitope. Hybridoma cell lines als Monoclonal antibodies are of much importance in both medicine and economics. Production of monoclonal antibodies takes place in the laboratory. First method of monoclonal antibodies was designed by two scientists, W. Kohler and C. Milstein. In their procedure, 1) Myeloma cells which are the tumor cells fused with spleen cells which are taken. Antibody-secreting B cells are immortalized by merging B lymphocytes and myeloma cells in the immunized mouse. The hybridoma cell line secreting the monoclonal antibody is then selected using limited dilution cloning. The monoclonal antibody is produced on a large scale by amplifying the culture of the cell strain

In fact, human monoclonal antibodies (hMAbs) produced by CHO cells have played a major role in both the diagnostic and therapeutic markets for decades. One of the first human-mouse chimeric MAbs to obtain FDA approval was Roche's rituximab treatment for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis Monoclonal Antibodies (Production and Uses) - AQA (9-1) A lesson designed for AQA Biology (9-1) which covers B6.5 and B6.6 in a 2 hour lesson. Some of the slides have been edited from resources I have found on TES

Monoclonal antibodies (Mabs): production by hybridoma

  1. Production of chimeric monoclonal antibodies, such as ReoPro® (abciximab, approved in 1994), used the same murine hybridoma process to generate antigen-specific mouse antibodies, but then replaced the constant region (the domains of the antibody that do not confer antigen specificity) of the mouse antibody with equivalent regions from a human.
  2. Monoclonal Antibody Production Service. Monoclonal antibody can be produced via traditional hybridoma technology or recombinant antibody technology. As an internationally recognized antibody expert, Biologics International Corp (BIC) provides monoclonal antibody production services which cover the complete full range of the antibody production process from antigen design through antibody.
  3. Monoclonal antibodies are produced by Hybridoma technique, developed by G Kohler and C Milstein (1975), for which they were awarded Nobel Prize in 1984. Principle A clone of B cell stimulated against a single epitope of antigen (i.e. antibody-producing plasma B cell) is fused with malignant antibody-producing myeloma cell to produce a hybridoma.
  4. Production of monoclonal antibodies can be done in both in vivo or in vitro procedures or combinations thereof. The first step in these methods is the production of hybrid cells that are capable of producing the antibodies. Animals are generally used in the generation of mAb-producing cells. The final result of the the procedure yields a cell.
  5. A study in U.S. nursing homes has shown for the first time that monoclonal antibodies, mass-produced in a laboratory, can protect people from developing symptomatic COVID-19
  6. Manufacturing antibodies in large quantities is required for many applications, including pre-clinical trials of antibody drugs.GenScript's large-scale antibody manufacturing services offer scale-up production of monoclonal and polyclonal antibodies from milligram to gram levels suitable for any application. To fit your every need, we have both in vitro antibody scale-up hybridoma technologies.
  7. Monoclonal antibodies (mAbs) originate from one unique parent cell, thus binding only to a single epitope. Monoclonal antibody discovery typically refers to the screening and identification of specific antibodies that target a specific epitope for the diagnosis and treatment of diseases, like the coronavirus for COVID-19.. There are several approaches to generating therapeutic mAbs

Production of monoclonal antibodies - Higher Tier

Large-Scale Production of Monoclonal Antibodies

  1. The identical antibodies they produced became known as monoclonal antibodies. Previously, the antibodies for use in medicine and diagnostics were extracted from blood. Scientists exposed animals to the desired antigen (usually a bacteria, virus, or toxin), causing the body to produce antibodies
  2. The production of traditional monoclonal antibodies also involves immunization of lab animals with antigens for the induction of antibody producing B-cells which are isolated and immortalized by the generation of hybridomas. Monoclonal antibodies bind to just one epitope, creating a higher level of specificity, and recombinant technology has.
  3. Antibodies are produced naturally by the immune system to recognize components of disease-causing agents, such as bacteria, viruses, or cancer cells, and to mark them for destruction. Monoclonal antibodies (mAbs) can be created in the lab by recombinant DNA technology to mimic those antibodies naturally generated by the immune system. As a class
  4. Normally, for monoclonal antibodies production, mammalian cells are used for their ability to correctly assemble and introduce post-translational modifications (Handbook of Therapeutic Antibodies 2E (2014)). Several mammalian cells can be used as host systems but the pattern of glycosylation has been showed to be unique for each system
HIGH THROUGHPUT ANTIBODY PRODUCTION

Monoclonal antibodies production - SlideShar

Isolation of human monoclonal antibodies by mammalian cell

Polyclonal and Monoclonal Antibody Production Microbiolog

Sino Biological has produced hundreds of endotoxin controlled monoclonal antibodies in various animal studies for customers worldwide. Our endotoxin controlled antibody production services can meet antibody quality suitable for human use. Specifically, if required, the endotoxin level can be reduced to as low as 0.01-0.05 EU/mg Mouse and Rat Monoclonal Antibody ProductionPhage Display & Hybridoma Technologies. BIOTEM has developed a fully recognized know-how in the generation and production of murine monoclonal antibodies. In addition since 1980 and with more than 150 projects per year, the team has a well established expertise in challenging targets (membrane protein. Scale Out cGMP production of monoclonal antibodies Our high-throughput manufacturing facility is scaled to multiple 2,000L bioreactors with an additional downstream suites. We employ single-use technologies for upstream and downstream process development and scale-up of mammalian cell culture-based monoclonal antibodies, leveraging process.

Monoclonal antibody - Wikipedi

High quality, well-validated antibodies are needed to mitigate irreproducibility and clarify conflicting data in science. We describe an epitope-directed monoclonal antibody (mAb) production. Monoclonal antibodies are produced by injecting an antigen into a host animal to initiate a humoral immune response. In most procedures, spleen cells from these hosts are fused in vitro with cultured malignant myeloma cells. Unique cell clones are isolated and those that survive the fusion step are known as hybridomas Monoclonal antibodies are used to treat many diseases, including some types of cancer. To make a monoclonal antibody, researchers first have to identify the right antigen to attack. Finding the right antigens for cancer cells is not always easy, and so far mAbs have proven to be more useful against some cancers than others Overall, this study provides a proof-of-principle for the rapid production of SARS-CoV-2 antigens or monoclonal antibodies in a plant expression system in order to produce diagnostic reagents.

An Introduction to ProteinsAntibodies | Free Full-Text | In Vivo Applications ofVaccination and antibodies - myDr

Monoclonal antibody production www

The term monoclonal antibody means that the man-made antibody is synthesized from cloned immune cells, and the identical monoclonal antibody produced binds to one type of antigen. Polyclonal antibodies are synthesized from different immune cells and the antibodies produced bind to multiple antigens Monoclonal Anti-TPH2 antibody produced in mouse Prestige Antibodies® Powered by Atlas Antibodies, clone CL2990, purified immunoglobulin, buffered aqueous glycerol solution; Synonyms: NTPH,FLJ37295; find Sigma-Aldrich-AMAB91108 MSDS, related peer-reviewed papers, technical documents, similar products & more at Sigma-Aldric Monoclonal antibodies are more complex and expensive to produce than other types of drugs. This makes them some of the most expensive drugs in the world, unaffordable for most of the world's population. The median price for monoclonal antibody treatments in the US ranges from $15,000 to $200,000 a year

Custom Monoclonal Antibody Production Sino Biologica

Monoclonal antibodies are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance or mimic the immune system's attack on cancer cells. They are designed to bind to antigens that are generally more numerous on the surface of cancer cells than healthy cells AtaGenix Monoclonal antibodies products have been strictly verified, and the quality is reliable. You can query the products you need according to the Monoclonal antibodies product name, or you can customize according to the needs of customers, and contact the online technical support website for preferential discounts What is the epitope sequence for product V6630, Monoclonal Anti-Vimentin antibody produced in mouse? Product V6630, Monoclonal Anti-Vimentin antibody, is a licensed antibody. The development and specification of this clone are specified in: Osborn, M., et al., Europ. J. Cell Biol., 34 137-143 (1984). In this paper the immunogen is porcine vimentin